Classification of rat hepatocellular proliferative lesions can vary between pathologists as the many qualitative histologic criteria have not been satisfactorily evaluated and ranked for prognostic value. Computer-assisted morphometry offers an objective method to evaluate certain cellular features. The Solt-Farber resistant hepatocyte model was used in this study to produce populations of rats with a full range of hepatocellular proliferative lesions. Cellular features within the lesions were then measured morphometrically and the data were analyzed by animal age and by subjective lesion diagnosis. The nuclear/cytoplasmic ratio followed by the cell area and nuclear area were found to be the most important parameters for separating microscopic foci and islands of cellular alteration, an early hyperplastic lesion, from other hepatocellular proliferative lesions. The coefficient of variation, as a relative measure of heterogeneity, increased in a linear manner for cell, nuclear and nucleolar areas as the animals aged and was significantly higher for cell and nuclear area in hepatocellular carcinoma compared to other hepatocellular proliferative lesions. Hepatocyte nodules (representing primarily late hyperplastic lesions) and persistent hepatocyte nodules (lesions with similarities to hepatocellular adenoma) could not be satisfactorily seaprated within the limits of this study. As these borderline lesions show a continuum of cytologic change, other features, such as architectural change, are necessary to satisfactorily classify them on a subjective basis. An alternative approach is to use discriminant functions derived from morphometric studies.
References
1.
1. Abmayr W, Deml E, Oesterle D, and Gössner W (1983). Nuclear morphology in preneoplastic lesions of rat liver. Anal. Quant. Cytol.5: 275–284.
2.
2. Anstrom A, De Pierre JW, and Eriksson LC (1983). Characterization of drug metabolizing systems in hyperplastic nodules from the livers of rats receiving 2-acetylaminofluorene in their diet. Carcinogenesis4: 577–581.
3.
3. Baak JPA and Oort J (1983). A Manual of Morphometry in Diagnostic Pathology.Springer-Verlag, New York.
4.
4. Baak JPA (1984). The Use and Disuse of Morphometry in the Diagnosis of Endometrial Hyerplasia and Carcinoma. Gustav Fisher Verlag, Stuttgart, pp. 20–33.
5.
5. Bannasch P (1984). Sequential cellular changes during chemical carcinogenesis. J. Cancer Res. Clin. Oncol.108: 11–22.
6.
6. Bannasch P, Hacker HJ, Klimek F, and Mayer D (1984). Hepatocellular glycogenesis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv. Enzyme Reg.22: 97–121.
7.
7. Becker FF (1976). Sequential phenotypic and biochemical alterations during chemical hepatocarcinogenesis. Cancer Res.36: 2563–2566.
8.
8. Boçking A, Aufferman W, Schwarz H, Bammert J, Dorrjer G, and Vucicuja S (1984). Cytology of prostatic carcinoma. Anal. Quant. Cytol.6: 74–88.
9.
9. Brooks PN and Roe FJC (1985). Hepatocellular adenoma, liver, rat. In: Digestive System, TC Jones, U Mohr, and RD Hunt (eds). Springer-Verlag, Berlin.
10.
10. Buchmann A, Kuhlmann W, Schwarz M, Kunz W, Wolf CR, Moll E, Friedberg T, and Oesch F (1985). Regulation of expression of four cytochrome P-450 isoenzymes NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis6: 513–600.
11.
11. Campbell HA, Pitot HC, Potter Van R, and Laishes BA (1982). Application of quantitative stereology to the evaluation of enzyme: Altered foci in rat liver. Cancer Res.42: 465–472.
12.
12. Cayama E, Tsuda H, Sarma DSR, and Farber E (1978). Initiation of chemical carcinogenesis requires cell proliferation. Nature (London)275: 60–62.
13.
13. Chasseaud LF (1979). The role of glutathione and glutathione S-transferase in the metabolism of chemical carcinogens and other electrophilic agents. Adv. Cancer Res.29: 175–274.
14.
14. Columbano A, Rajalakshmi S, and Sarma DSR (1981). Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res.41: 2079–2083.
15.
15. Elias H and Hyde DM (1983). A Guide to Practical Stereology.S Karger AG, Basel.
16.
16. Enomoto K and Farber E (1982). Kinetics of phenotypic maturation of remodeling of hyperplastic nodules during liver carcinogenesis. Cancer Res.42: 2330–2335.
17.
17. Eriksson LC, Ahluwalia M, Spiewak J, Lee G, Sarma DSR, Roomi MW, and Farber E (1983). Distinctive jbiochemical pattern associated with resistance of hepatocytes in hepatocyte nodules during liver carcinogenesis. Environ. Health Perspect.49: 171–174.
18.
18. Farber E (1980). The sequential analysis of liver cancer induction. Biochim. Biophys. Acta605: 149–166.
19.
19. Farber E and Cameron R (1980). The sequential analysis of cancer development. Adv. Cancer Res.35: 125–226.
20.
20. Farber E (1984). The multistep nature of cancer development. Cancer Res.44: 4217–4223.
21.
21. Farber E and Sarma DSR (1987). Hepatocarcinogenesis: A dynamic cellular perspective. Lab. Invest.56: 4–22.
22.
22. Farber E and Sarma DSR (1986). Chemical carcinogenesis: The liver as a model. Pathol. Immunopathol. Res.5: 1–28.
23.
23. Farber E (1984). The biochemistry of preneoplastic liver: A common metabolic pattern in hepatocyte nodules. Can. J. Biochem. Cell. Biol.62: 486–494.
25. Hall TL and Fu YS (1985). Biology of disease: Applications of quantitative microscopy in tumor pathology. Lab. Invest.53: 5–21.
26.
26. Hayes MA, Becker R, and Farber E (1985). A comparison of alternativaea methods of 2-AAF administration for the selection of hepatocyte nodules in the resistant hepatocyte model.Proceedings ACCR26: 135.
27.
27. Higgins GM and Anderson RM (1931). Experimental pathology of the liver: Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol.12: 186–202.
28.
28. Heppner GH (1984). Tumor heterogeneity. Cancer Res.44: 2259–2265.
29.
29. Institute of Laboratory Animal Resources, National Research Council, National Academy of Sciences (1980). Histologic typing of liver tumors of the rat. J. Natl. Cancer Inst.61: 178–206.
30.
30. Losos GJ, McMillan I, Minder ChE, and Soulsby K (1982). Quantitative methods in the study of the pathogenesis of hemoprotozoal diseases. Parasitology84: 537–565.
31.
31. Maronpot RR, Montgomery CA Jr, Boorman GA, and McConnell EE (1986). National toxicology program nomenclature for hepatoproliferative lesions of rats. Toxicol. Pathol.14: 263–275.
32.
32. Maronpot RR and Borman GA (1982). Interpretation of rodent hepatoproliferative alterations and hepatocellular tumors in chemical safety assessment. Toxicol. Pathol.10: 71–80.
33.
33. Maronpot RR (1985). Considerations in the evaluation and interpretation of long-term animal bioassays for carcinogenicity. In: Handbook of Carcinogen Testing, HA Mitman and EK Weisburger (eds). Noyes Publications, Park Ridge, NJ, pp. 372–382.
34.
34. Oesch F (1983). Drug detoxification: Epoxide hydrolase. Prog. Clin. Biol. Res.135: 81–105.
35.
35. Ogawa K, Medine A, and Farber E (1979). Sequential analysis of hepatic carcinogenesis: A comparative study of the ultrastructure of preneoplastic, malignant, prenatal, postnatal and regenerative liver. Lab. Invest.41: 22–35.
36.
36. Ogawa K, Medline A, and Farber E (1979). Sequential analysis of hepatic carcinogenesis: The comparative architecture of preneoplastic, malignant, prenatal, postnatal and regenerating liver. Br. J. Cancer40: 782–790.
37.
37. Ogawa K, Solt DB, and Farber E (1980). Phenotypic diversity as an early property of putative prenéoplastic hepatocyte populations in liver carcinogenesis. Cancer Res.40: 723–725.
38.
38. Poste G and Greig R (1983). The experimental and clinical implications of cellular heterogeneity in malignant tumors. J. Cancer Res. Clin. Oncol.106: 159–170.
39.
39. Reuber MD and Firminger HI (1963). Morphologic and biologic correlation of lesions obtained in hepatic carcinogenesis in AXC rats given 0.025 percent N-2-fluorenyldiacetamide. J. Natl. Cancer Inst.31: 1407–1430.
40.
40. Roomi MW, Ho RK, Cameron RG, Sarma DSR, and Farber E (1985). A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat. Cancer Res.45: 564–571.
41.
41. Rotstein JB, Sarma DSR, and Farber E (1986). Sequential alterations in growth control and cell dynamics of hepatocytes in early precancerous steps in hepatocarcinogenesis. Cancer Res.46: 2377–2385.
42.
42. Sato K, Kitahara A, Satoh K, Ishikawa T, Tatematsu M, and Ito N (1984). The placental form of glutahione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis. Gann75: 199–202.
43.
43. Schauer A and Kunze E (1976). Tumours of the liver. In: Pathology of Tumours in Laboratory Animals, Vol. 1, Tumours of the Rat. IARC Scientific Publication No. 6, Lyon.
44.
44. Schnipper LE (1986). Clinical implications of tumor-cell heterogeneity. N. Engl. J. Med.314: 1423–1431.
45.
45. Solt D and Farber E (1976). New principle for the analysis of chemical carcinogenesis. Nature263: 701–703.
46.
46. Solt DB, Medline A, and Farber E (1977). Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am. J. Pathol.88: 595–609.
47.
47. Squire RA and Levitt MH (1975). Report of a workshop classification of specific hepatocellular lesions in rats. Cancer Res.35: 3214–3223.
48.
48. Steel RGD and Torrie JH (1960). Principles and Procedures of Statistics.McGraw-Hill Book Company Inc., New York.
49.
49. Tatematsu M, Nagamine Y, and Farber E (1983). Redifferentiation as a basis for remodelling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res.43: 5049–5058.
50.
50. Tatematsu M, Lee G, Hayes MA, and Farber E (1987). Progression in hepatocarcinogenesis: Differences in growth and behaviour of transplants of early and late hepatocyte nodules in the spleen. Cancer Res.47: 4699–4705.
51.
51. Tourassis VD, Dekker A, and Preston K (1983). Relationship between cell size and weight of the human liver: An automated morphometric study. Anal. Quant. Cytol.5: 43–54.
52.
52. Tsuda H, Lee G, and Farber E (1980). Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Cancer Res.40: 1157–1164.
53.
53. Ward JM (1981). Morphology of foci of altered hepatocytes and naturally occurring hepatocellular tumors in F-344 rats. Virchows Arch. (Pathol. Anat.)390: 339–345.
54.
54. Watanabe S, Okita K, Harada T, Kodama T, Numa Y, Takemoto T, and Takahashi M (1983). Morphologic studies of the liver cell dysplasia. Cancer51: 2197–2205.
55.
55. Weibel ER, Stäubli W, Griägi HR, and Hess FA (1969). Correlated morphometric and biochemical studies on the liver cell. J. Cell Biol.42: 68–91.
56.
56. Williams GM, Klaiber M, and Farber E (1977). Differences in growth of transplants of liver, liver hyperplastic nodules, and hepatocellular carcinomas in the mammary fat pad. Am. J. Pathol.89: 379–390.
57.
57. Williams MA (1977). Quantitative Methods in Biology, Vol. 6, Part II. In: The Series–-Practical Methods in Electron Microscopy, AM Glauert (ed). Elsevier North-Holland Inc., New York.
58.
58. Woodruff MFA (1983). Cellular heterogeneity in tumors. Br. J. Cancer47: 589–594.
